Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies
There is an urgent need for earlier diagnosis of malignancies and more stringent monitoring of relapses after antitumor therapy. In addition, new prognostic markers are needed for risk stratification and design of individualized cancer therapies. New diagnostic and prognostic parameters should overc...
| Published in: | Clinical and Developmental Immunology |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Online Access: | http://dx.doi.org/10.1155/2010/721531 |